Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No visible changes to study details or page layout.SummaryDifference0.0%

- Check41 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedThe footer now shows Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check70 days agoChange DetectedThe update is a minor site version change from v3.4.0 to v3.4.1; no study data, endpoints, or locations appear to have changed.SummaryDifference0.0%

- Check84 days agoChange DetectedShow glossary feature added. Metadata updates include capitalization tweaks for QC criteria and No FEAR Act data, and the revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check91 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.